Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

Clin Chim Acta. 2020 Jun:505:190-191. doi: 10.1016/j.cca.2020.03.004. Epub 2020 Mar 4.

Authors

Giuseppe Lippi¹, Mario Plebani²

Affiliations

¹ Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
² Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy. Electronic address: mario.plebani@unipd.it.

No abstract available

Keywords: COVID-19; Coronavirus; Procalcitonin; Prognosis.

Publication types

Letter
Meta-Analysis

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Coronavirus Infections / blood*
Coronavirus Infections / diagnosis
Humans
Pandemics
Pneumonia, Viral / blood*
Procalcitonin / blood*
Risk Factors
SARS-CoV-2

Substances

Procalcitonin